Atlas Trials

Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia

Clinical trial NCT01134263 · COMPLETED

Trial details

NCT number
NCT01134263
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Dengue FeverDengue Hemorrhagic Fever
Start date
2010-10-05
Primary completion
2012-11-01
Enrollment
715

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.